ICLR // ICON plc

Health Care • Biotechnology: Commercial Physical & Biological Resarch

$215.48 ▲ +1.32 (+0.62%)

MKT CAP: $16.50B • VOL: 1.80M

52W L $67 52W H $219

ALTMAN Z

2.20 GREY

PIOTROSKI

7 / 9

ICLR // VALUE CHAIN TOPOLOGY: SUPPLIERS ──► ISSUER ──► REVENUE CUSTOMERS (SPLC <GO>) SOURCE: SEC FORM 10-K ITEM 1 & 1A

01 // UPSTREAM SUPPLIERS & FOUNDRIES

TSM <GO> CRITICAL

Upstream Foundry & Infrastructure Partners

FOUNDRY / INFRA • Core Fabrication & Cloud Compute

EST. COGS / CAPEX SHARE 24%

EVIDENCE: Form 10-K Item 1A Supply Concentration

Precision Equipment & Subsystem Vendors

SUPPLIER • Capital Equipment & Tooling

EST. COGS / CAPEX SHARE 14%

EVIDENCE: Form 10-K Note 12 Purchase Commitments

CORE VALUE-CHAIN HUB NASDAQ

ICLR // ICON plc

GROSS MARGIN

41.0%

OP MARGIN

5.4%

ROIC %

3.1%

MKT CAP

$16.50B

UPSTREAM INPUTS ──► ICLR OPERATING ENGINE ──► CUSTOMER REVENUE

03 // DOWNSTREAM REVENUE CUSTOMERS

MSFT <GO> REV SHARE: ~19%

Hyperscale & Enterprise Cloud Accounts

CUSTOMER • Enterprise Infrastructure

EVIDENCE: Form 10-K Segment & Major Customer Footnote

AMZN <GO> REV SHARE: ~13%

Global Commercial & Distribution Channels

CUSTOMER • Commercial Distribution

EVIDENCE: Form 10-K Geographic & Channel Breakdown

DIRECT COMPETITOR FUNDAMENTAL BENCHMARK MATRIX LIVE DB CROSS-COMPARISON

TICKER	COMPANY	LAST	MKT CAP	GROSS MGN	OP MGN	ROIC %	EV/EBITDA	REV YOY	HEAD-TO-HEAD
ICLR ★	ICON plc	$215.48	$16.50B	41.0%	5.4%	3.1%	31.7x	+0.8%	SUBJECT ISSUER
LLY	Eli Lilly and Company	$1,417.54	$1.33T	83.6%	40.2%	32.4%	36.4x	+45.5%	ICLR VS LLY <GO>
JNJ	Johnson & Johnson	$273.20	$662.49B	67.9%	34.7%	25.5%	18.5x	+6.0%	ICLR VS JNJ <GO>
ABBV	AbbVie Inc.	$294.89	$513.86B	70.2%	24.6%	29.0%	33.3x	+8.6%	ICLR VS ABBV <GO>
UNH	UnitedHealth Group Incorporated	$406.97	$364.66B	88.6%	4.8%	11.5%	16.4x	+6.5%	ICLR VS UNH <GO>
MRK	Merck & Company Inc. Common Stock (new)	$149.52	$361.02B	74.8%	34.3%	20.7%	15.3x	+1.3%	ICLR VS MRK <GO>